Correlation Between Cue Biopharma and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Cue Biopharma and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Reviva Pharmaceuticals.
Diversification Opportunities for Cue Biopharma and Reviva Pharmaceuticals
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cue and Reviva is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cue Biopharma and Reviva Pharmaceuticals
Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the Reviva Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Cue Biopharma is 1.02 times less risky than Reviva Pharmaceuticals. The stock trades about -0.01 of its potential returns per unit of risk. The Reviva Pharmaceuticals Holdings is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 386.00 in Reviva Pharmaceuticals Holdings on August 25, 2024 and sell it today you would lose (272.00) from holding Reviva Pharmaceuticals Holdings or give up 70.47% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. Reviva Pharmaceuticals Holding
Performance |
| Timeline |
| Cue Biopharma |
| Reviva Pharmaceuticals |
Cue Biopharma and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Reviva Pharmaceuticals
The main advantage of trading using opposite Cue Biopharma and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
| Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |